Drugs / Extended Release Metformin Hydrochloride
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04576104 | Nov 2021 → Aug 2025 overdue | atypical endometrial hyperplasia, endometrial carcinoma | Northwestern University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Extended Release Metformin Hydrochloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04576104 ↗ |
| Route | Oral | “Given PO” NCT04576104 ↗ |